Evaluation of a Continuous Glucose Monitoring Based Regimen in a Resource-Limited Setting: A Pilot Study
Our study did not find that CGM titrated regimens resulted in a statistically significant difference in HbA1c change at 3 months compared to non-CGM based treatment. This may indicate that while diabetes technology can help achieve glucose goals in more controlled settings, optimal results in the real world is influenced by many factors, such as insurance coverage, patient adoption, and provider training. More research can be done on identifying factors that yield optimal results in CGM utilization in outpatient settings.
Authors
- Rebecca Khaimova (ORCID: https://orcid.org/0000-0001-5028-0635)
- Rose Calixte (ORCID: https://orcid.org/0000-0002-2020-5906)
- Shannon Ramdeen (ORCID: https://orcid.org/0009-0002-3105-1153)
- Claudette Donatien (ORCID: https://orcid.org/0009-0003-5779-2088)
- Aliaksandr Budovich (ORCID: https://orcid.org/0009-0000-0718-0292)
- Natasha Thomas
- Qudsia S. Banu (ORCID: https://orcid.org/0009-0009-1190-1764)
Institutions
- Northwell Health (US)
- SUNY Downstate Health Sciences University (US)
- Brookdale University Hospital and Medical Center (US)
- Yale New Haven Health System (US)
Publication Details
- Journal
- Clinical Medicine Insights Endocrinology and Diabetes
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1177/11795514251389034
- Citations
- 1
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.29